Published in Mol Neurodegener on March 18, 2008
Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue. PLoS One (2010) 2.49
Natural products reveal cancer cell dependence on oxysterol-binding proteins. Nat Chem Biol (2011) 1.31
Lipoprotein receptors and cholesterol in APP trafficking and proteolytic processing, implications for Alzheimer's disease. Semin Cell Dev Biol (2008) 1.25
LRRK2 and the stress response: interaction with MKKs and JNK-interacting proteins. Neurodegener Dis (2010) 0.95
Oxysterols and their cellular effectors. Biomolecules (2012) 0.92
Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun (1984) 20.07
Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A (1985) 16.10
Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science (1999) 13.19
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet (2007) 12.13
A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature (1999) 10.36
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet (2007) 9.80
An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature (1996) 7.86
A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature (2001) 7.35
Reconstitution of gamma-secretase activity. Nat Cell Biol (2003) 4.66
Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proc Natl Acad Sci U S A (2005) 4.34
Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci U S A (1999) 3.85
Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J Biol Chem (1998) 3.83
Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol Cell Neurosci (1999) 3.77
Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis (2000) 3.46
Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin. Nat Cell Biol (2005) 2.91
GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Abeta42. EMBO J (2007) 2.61
Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science (1992) 2.50
Translocation of oxysterol binding protein to Golgi apparatus triggered by ligand binding. J Cell Biol (1992) 2.11
Vesicle-associated membrane protein-associated protein-A (VAP-A) interacts with the oxysterol-binding protein to modify export from the endoplasmic reticulum. J Biol Chem (2002) 2.11
Analysis of oxysterol binding protein homologue Kes1p function in regulation of Sec14p-dependent protein transport from the yeast Golgi complex. J Cell Biol (2002) 2.07
Nonvesicular sterol movement from plasma membrane to ER requires oxysterol-binding protein-related proteins and phosphoinositides. J Cell Biol (2006) 2.04
Oxysterol biosynthetic enzymes. Biochim Biophys Acta (2000) 2.00
OSBP is a cholesterol-regulated scaffolding protein in control of ERK 1/2 activation. Science (2005) 1.99
Homodimerization of amyloid precursor protein and its implication in the amyloidogenic pathway of Alzheimer's disease. J Biol Chem (2001) 1.96
Interaction of the cytosolic domains of sorLA/LR11 with the amyloid precursor protein (APP) and beta-secretase beta-site APP-cleaving enzyme. J Neurosci (2006) 1.83
The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease. J Biol Chem (2004) 1.75
Ceramide stabilizes beta-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid beta-peptide biogenesis. J Biol Chem (2003) 1.73
Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. J Neurochem (1996) 1.66
The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer's disease. Mol Cell Neurosci (2007) 1.66
The role of cholesterol in the biosynthesis of beta-amyloid. Neuroreport (1999) 1.59
Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein. Biochem J (1999) 1.47
The OSBP-related proteins: a novel protein family involved in vesicle transport, cellular lipid metabolism, and cell signalling. Biochim Biophys Acta (2003) 1.46
Differential expression of cholesterol hydroxylases in Alzheimer's disease. J Biol Chem (2004) 1.46
The OSBP-related protein family in humans. J Lipid Res (2001) 1.40
Murine notch homologs (N1-4) undergo presenilin-dependent proteolysis. J Biol Chem (2001) 1.39
22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion. J Biol Chem (2003) 1.37
Novel members of the human oxysterol-binding protein family bind phospholipids and regulate vesicle transport. J Biol Chem (2001) 1.31
Expression of liver X receptor target genes decreases cellular amyloid beta peptide secretion. J Biol Chem (2003) 1.27
Purification of oxysterol binding protein from hamster liver cytosol. J Biol Chem (1989) 1.26
OSBP-related protein 8 (ORP8) suppresses ABCA1 expression and cholesterol efflux from macrophages. J Biol Chem (2007) 1.23
A fluid connection: cholesterol and Abeta. Proc Natl Acad Sci U S A (2001) 1.22
Fluorescence resonance energy transfer analysis of cytochromes P450 2C2 and 2E1 molecular interactions in living cells. J Biol Chem (2003) 1.21
The mammalian oxysterol-binding protein-related proteins (ORPs) bind 25-hydroxycholesterol in an evolutionarily conserved pocket. Biochem J (2007) 1.20
Surface expression of inward rectifier potassium channels is controlled by selective Golgi export. J Biol Chem (2003) 1.20
Altered regulation of cholesterol and cholesteryl ester synthesis in Chinese-hamster ovary cells overexpressing the oxysterol-binding protein is dependent on the pleckstrin homology domain. Biochem J (1997) 1.19
Visualization of APP dimerization and APP-Notch2 heterodimerization in living cells using bimolecular fluorescence complementation. J Neurochem (2006) 1.16
Oxidative stress induces increase in intracellular amyloid beta-protein production and selective activation of betaI and betaII PKCs in NT2 cells. Biochem Biophys Res Commun (2000) 1.14
Chinese hamster ovary cells overexpressing the oxysterol binding protein (OSBP) display enhanced synthesis of sphingomyelin in response to 25-hydroxycholesterol. J Lipid Res (1999) 1.11
The OSBP-related proteins (ORPs): global sterol sensors for co-ordination of cellular lipid metabolism, membrane trafficking and signalling processes? Biochem Soc Trans (2006) 1.04
Modulation of amyloid precursor protein cleavage by cellular sphingolipids. J Biol Chem (2004) 1.00
The amyloid precursor protein of Alzheimer's disease and the Abeta peptide. Neuropathol Appl Neurobiol (1999) 1.00
Overexpression of OSBP-related protein 2 (ORP2) induces changes in cellular cholesterol metabolism and enhances endocytosis. Biochem J (2005) 0.97
Amyloid precursor protein interacts with notch receptors. J Neurosci Res (2005) 0.93
Family of human oxysterol binding protein (OSBP) homologues. A novel member implicated in brain sterol metabolism. J Lipid Res (1999) 0.84
Novel mutations introduced at the beta-site of amyloid beta protein precursor enhance the production of amyloid beta peptide by BACE1 in vitro and in cells. J Alzheimers Dis (2005) 0.84
Muscarine enhances soluble amyloid precursor protein secretion in human neuroblastoma SH-SY5Y by a pathway dependent on protein kinase C(alpha), src-tyrosine kinase and extracellular signal-regulated kinase but not phospholipase C. Brain Res Mol Brain Res (2002) 0.82
The spectrum of disease in chronic traumatic encephalopathy. Brain (2012) 5.10
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ (2010) 3.98
Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17. Proc Natl Acad Sci U S A (2007) 3.13
CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum Mol Genet (2004) 3.12
Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor. J Neurosci (2002) 2.87
Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons. Neuron (2002) 2.65
Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue. PLoS One (2010) 2.49
Sex-dependent liver gene expression is extensive and largely dependent upon signal transducer and activator of transcription 5b (STAT5b): STAT5b-dependent activation of male genes and repression of female genes revealed by microarray analysis. Mol Endocrinol (2006) 2.17
Aggregated and monomeric alpha-synuclein bind to the S6' proteasomal protein and inhibit proteasomal function. J Biol Chem (2003) 1.91
Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation. Proc Natl Acad Sci U S A (2009) 1.87
Local RNA translation at the synapse and in disease. J Neurosci (2011) 1.83
Assessment of the emergence of Alzheimer's disease following coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty. J Alzheimers Dis (2005) 1.74
LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans. J Neurosci (2009) 1.64
Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. Dement Geriatr Cogn Disord (2009) 1.58
Molecular insights into the pathogenesis of Alzheimer's disease and its relationship to normal aging. PLoS One (2011) 1.57
LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's disease. Proc Natl Acad Sci U S A (2006) 1.50
L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for alpha5-containing GABAA receptors. Neuropharmacology (2006) 1.46
Differential expression of cholesterol hydroxylases in Alzheimer's disease. J Biol Chem (2004) 1.46
Leptin: a novel therapeutic strategy for Alzheimer's disease. J Alzheimers Dis (2009) 1.42
The Parkinson's disease associated LRRK2 exhibits weaker in vitro phosphorylation of 4E-BP compared to autophosphorylation. PLoS One (2010) 1.39
Gene profile analysis implicates Klotho as an important contributor to aging changes in brain white matter of the rhesus monkey. Glia (2008) 1.37
The cytosolic endopeptidase, thimet oligopeptidase, destroys antigenic peptides and limits the extent of MHC class I antigen presentation. Immunity (2003) 1.36
Contrasting pathology of the stress granule proteins TIA-1 and G3BP in tauopathies. J Neurosci (2012) 1.34
MKK6 binds and regulates expression of Parkinson's disease-related protein LRRK2. J Neurochem (2010) 1.28
Identification of genetic pathways activated by the androgen receptor during the induction of proliferation in the ventral prostate gland. J Biol Chem (2003) 1.28
Group III metabotropic glutamate-receptor-mediated modulation of excitatory transmission in rodent substantia nigra pars compacta dopamine neurons. J Pharmacol Exp Ther (2005) 1.24
Parallel synthesis of N-biaryl quinolone carboxylic acids as selective M(1) positive allosteric modulators. Bioorg Med Chem Lett (2009) 1.22
Rac1 protein rescues neurite retraction caused by G2019S leucine-rich repeat kinase 2 (LRRK2). J Biol Chem (2011) 1.22
Role of STAT5a in regulation of sex-specific gene expression in female but not male mouse liver revealed by microarray analysis. Physiol Genomics (2007) 1.20
Inhibition of calcineurin-mediated endocytosis and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors prevents amyloid beta oligomer-induced synaptic disruption. J Biol Chem (2009) 1.18
A protocol for the differentiation of human embryonic stem cells into dopaminergic neurons using only chemically defined human additives: Studies in vitro and in vivo. Brain Res (2006) 1.17
Visualization of APP dimerization and APP-Notch2 heterodimerization in living cells using bimolecular fluorescence complementation. J Neurochem (2006) 1.16
Adaptation in human visual cortex as a mechanism for rapid discrimination of aversive stimuli. Neuroimage (2007) 1.13
Role of stress granules and RNA-binding proteins in neurodegeneration: a mini-review. Gerontology (2013) 1.11
Retracted A regulatory circuit mediating convergence between Nurr1 transcriptional regulation and Wnt signaling. Mol Cell Biol (2007) 1.11
Characterization of five evolutionary conserved regions of the human tyrosine hydroxylase (TH) promoter: implications for the engineering of a human TH minimal promoter assembled in a self-inactivating lentiviral vector system. J Cell Physiol (2005) 1.08
The antiaging protein Klotho enhances oligodendrocyte maturation and myelination of the CNS. J Neurosci (2013) 1.08
Regulation of physiologic actions of LRRK2: focus on autophagy. Neurodegener Dis (2011) 1.07
alpha-Synuclein interacts with phospholipase D isozymes and inhibits pervanadate-induced phospholipase D activation in human embryonic kidney-293 cells. J Biol Chem (2002) 1.06
Androgen-mediated improvement of body composition and muscle function involves a novel early transcriptional program including IGF1, mechano growth factor, and induction of {beta}-catenin. J Mol Endocrinol (2009) 1.06
Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease. Neurobiol Dis (2005) 1.04
Age-related molecular reorganization at the node of Ranvier. J Comp Neurol (2006) 1.02
Beyond amyloid: the next generation of Alzheimer's disease therapeutics. Mol Interv (2007) 1.01
Promoter methylation and age-related downregulation of Klotho in rhesus monkey. Age (Dordr) (2011) 1.01
Leucine-rich repeat kinase 2 induces alpha-synuclein expression via the extracellular signal-regulated kinase pathway. Cell Signal (2010) 1.01
Iatrogenic risk factors for Alzheimer's disease: surgery and anesthesia. J Alzheimers Dis (2010) 1.00
High-throughput screening by RNA interference: control of two distinct types of variance. Cell Cycle (2007) 1.00
Magnesium inhibits spontaneous and iron-induced aggregation of alpha-synuclein. J Biol Chem (2002) 1.00
ALS-linked mutations enlarge TDP-43-enriched neuronal RNA granules in the dendritic arbor. J Neurosci (2014) 1.00
Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators. Bioorg Med Chem Lett (2010) 0.99
Future-oriented decision-making in Generalized Anxiety Disorder is evident across different versions of the Iowa Gambling Task. J Behav Ther Exp Psychiatry (2009) 0.98
Increased nuclear factor-erythroid 2 p45-related factor 2 activity protects SH-SY5Y cells against oxidative damage. J Neurochem (2005) 0.97
The heat shock transcription factor Hsf1 is downregulated in DNA damage-associated senescence, contributing to the maintenance of senescence phenotype. Aging Cell (2012) 0.96
Androgenic induction of growth and differentiation in the rodent uterus involves the modulation of estrogen-regulated genetic pathways. Endocrinology (2004) 0.96
Quinolizidinone carboxylic acid selective M1 allosteric modulators: SAR in the piperidine series. Bioorg Med Chem Lett (2011) 0.96
Pathogenic LRRK2 mutations do not alter gene expression in cell model systems or human brain tissue. PLoS One (2011) 0.96
Identification of novel small molecules that elevate Klotho expression. Biochem J (2012) 0.95
Worry, generalized anxiety disorder, and emotion: evidence from the EEG gamma band. Biol Psychol (2008) 0.94
Stability of RNA from the retina and retinal pigment epithelium in a porcine model simulating human eye bank conditions. Invest Ophthalmol Vis Sci (2003) 0.94
Pyridine containing M(1) positive allosteric modulators with reduced plasma protein binding. Bioorg Med Chem Lett (2009) 0.94
Discovery of a selective allosteric M1 receptor modulator with suitable development properties based on a quinolizidinone carboxylic acid scaffold. J Med Chem (2011) 0.93
Amyloid precursor protein interacts with notch receptors. J Neurosci Res (2005) 0.93
What's behind the decline? The role of white matter in brain aging. Neurochem Res (2007) 0.93
Discrete expression of TRPV2 within the hypothalamo-neurohypophysial system: Implications for regulatory activity within the hypothalamic-pituitary-adrenal axis. J Comp Neurol (2004) 0.92
Oxidative damage in the olfactory system in Alzheimer's disease. Acta Neuropathol (2003) 0.92
Acquisition of affective dispositions in dementia patients. Neuropsychologia (2006) 0.91
Investigating convergent actions of genes linked to familial Parkinson's disease. Neurodegener Dis (2008) 0.91
Acyl peptide hydrolase, a serine proteinase isolated from conditioned medium of neuroblastoma cells, degrades the amyloid-beta peptide. J Neurochem (2007) 0.90
Identification and localization of major soluble vitreous proteins in human ocular tissue. Am J Ophthalmol (2004) 0.90
Hydroxy cycloalkyl fused pyridone carboxylic acid M(1) positive allosteric modulators. Bioorg Med Chem Lett (2010) 0.90
N-heterocyclic derived M1 positive allosteric modulators. Bioorg Med Chem Lett (2010) 0.90
Age-dependent accumulation of ubiquitinated 2',3'-cyclic nucleotide 3'-phosphodiesterase in myelin lipid rafts. Glia (2008) 0.90
beta-Synuclein reduces proteasomal inhibition by alpha-synuclein but not gamma-synuclein. J Biol Chem (2004) 0.89
The muscarinic M1 receptor positive allosteric modulator PQCA improves cognitive measures in rat, cynomolgus macaque, and rhesus macaque. Psychopharmacology (Berl) (2012) 0.89
Induced pluripotent stem cell modeling of multisystemic, hereditary transthyretin amyloidosis. Stem Cell Reports (2013) 0.89
The familial hemiplegic migraine mutation R192Q reduces G-protein-mediated inhibition of P/Q-type (Ca(V)2.1) calcium channels expressed in human embryonic kidney cells. J Physiol (2003) 0.89
Redox proteomics analyses of the influence of co-expression of wild-type or mutated LRRK2 and Tau on C. elegans protein expression and oxidative modification: relevance to Parkinson disease. Antioxid Redox Signal (2012) 0.88
A genome wide analysis of ubiquitin ligases in APP processing identifies a novel regulator of BACE1 mRNA levels. Mol Cell Neurosci (2006) 0.88
Cell-type dependent modulation of Notch signaling by the amyloid precursor protein. J Neurochem (2010) 0.88
Lowering of amyloid beta peptide production with a small molecule inhibitor of amyloid-β precursor protein dimerization. Am J Neurodegener Dis (2012) 0.87
Gene expression analyses in cynomolgus monkeys provides mechanistic insight into high-density lipoprotein-cholesterol reduction by androgens in primates. Endocrinology (2008) 0.87
Gene expression changes associated with the endoplasmic reticulum stress response induced by microsomal cytochrome p450 overproduction. J Biol Chem (2004) 0.87
Tyrosine hydroxylase gene regulation in human neuronal progenitor cells does not depend on Nurr1 as in the murine and rat systems. J Cell Physiol (2006) 0.86
Characterization of insulin degrading enzyme and other amyloid-β degrading proteases in human serum: a role in Alzheimer's disease? J Alzheimers Dis (2012) 0.86
Watching worms whither: modeling neurodegeneration in C. elegans. Prog Mol Biol Transl Sci (2011) 0.86
Biochemical and functional characterization of the klotho-VS polymorphism implicated in aging and disease risk. J Biol Chem (2013) 0.86
Acyl peptide hydrolase degrades monomeric and oligomeric amyloid-beta peptide. Mol Neurodegener (2009) 0.86
Clozapine potentiation of N-methyl-D-aspartate receptor currents in the nucleus accumbens: role of NR2B and protein kinase A/Src kinases. J Pharmacol Exp Ther (2005) 0.86
Identification of cleavage sites leading to the shed form of the anti-aging protein klotho. Biochemistry (2014) 0.86
6,7-Dihydro-2-benzothiophen-4(5H)-ones: a novel class of GABA-A alpha5 receptor inverse agonists. J Med Chem (2002) 0.85
Abnormal oscillatory brain dynamics in schizophrenia: a sign of deviant communication in neural network? BMC Psychiatry (2007) 0.85
Following the leader: fibrillization of alpha-synuclein and tau. Exp Neurol (2004) 0.85